Penimeroandranoid E, an Uncommon 6/6/6/5 Spirocyclic Meroterpenoid from the Deep-Sea-Derived Fungus Penicillium mali, Inhibits Osteoclastogenesis
Marine Drugs · 26.10.2026 · 24 (11) · 378
DOI: 10.3390/md24110378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, online erschienen am 26.10.2026. Verfasst von A-Long Zhang und 4 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Chemical investigation of the deep-sea-derived fungus Penicillium mali MCCC 3A00140 afforded two new compounds, penimeroandranoid E (1) and malistatin (2), together with 16 known ones (3–18). Their structures were established by extensive spectroscopic analyses, including 1D and 2D NMR and HRESIMS. The relative configuration of 1 was supported by single-crystal X-ray diffraction, and its absolute configuration was assigned by comparison of the experimental and calculated electronic circular dichroism (ECD) spectra. Compound 1 was the meroterpenoid reported to possess a 6/6/6/5 spirocyclic framework—a spiro-fused variant of the 6/6/6/5 carbocyclic system that was characteristic of andrastin-type DMOA-derived meroterpenoids—and its structure and relative configuration were established by single-crystal X-ray diffraction. The stereochemical assignment of 2 was based on NOESY correlations and biosynthetic analogy with related statins. Screening of all isolates at 20 μM in a receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis model using primary murine bone marrow-derived macrophages identified 1 as the bioactive secondary metabolite. Compound 1 reduced the formation of tartrate-resistant acid phosphatase-positive multinucleated osteoclasts at 12.5–50 μM without decreasing cell viability after 48 h at concentrations up to 50 μM. These findings expand the chemical diversity of fungal meroterpenoids and identify 1 as a structurally distinctive anti-osteoclastogenic metabolite warranting further mechanistic investigation.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, A., Guo, Y., Zou, Z., Yang, X., & Xie, C. (2026). Penimeroandranoid E, an Uncommon 6/6/6/5 Spirocyclic Meroterpenoid from the Deep-Sea-Derived Fungus Penicillium mali, Inhibits Osteoclastogenesis. Marine Drugs, 24(11), 378. https://doi.org/10.3390/md24110378
Vancouver
Zhang A, Guo Y, Zou Z, Yang X, Xie C. Penimeroandranoid E, an Uncommon 6/6/6/5 Spirocyclic Meroterpenoid from the Deep-Sea-Derived Fungus Penicillium mali, Inhibits Osteoclastogenesis. Marine Drugs. 2026;24(11):378. doi:10.3390/md24110378
BibTeX
@article{Zhang2026,
author = {Zhang, A-Long and Guo, Yan-Qing and Zou, Zheng-Biao and Yang, Xian-Wen and Xie, Chun-Lan},
title = {Penimeroandranoid E, an Uncommon 6/6/6/5 Spirocyclic Meroterpenoid from the Deep-Sea-Derived Fungus Penicillium mali, Inhibits Osteoclastogenesis},
journal = {Marine Drugs},
year = {2026},
volume = {24},
number = {11},
pages = {378},
doi = {10.3390/md24110378}
}
EUVIMED